AstraZeneca will start making at-home deliveries for FluMist, its nasal spray flu vaccine.
FluMist, on the market since 2003, was previously only available at pharmacies or doctors’ offices.
The pharmaceutical and biotechnology company received approval in the United States last year for self- or caregiver-administration at home.
Trending: Hank Kunneman Reveals New Leader To Emerge In Russia
ABC News did a spotlight on the nasal spray vaccine:
AstraZeneca is making flu protection more convenient with the launch of an at-home delivery option for FluMist, its nasal spray flu vaccine, the company has announced.@ABC News’ Chief Medical Correspondent @drtaranarula tells us more. https://t.co/CNwOvk5Mjm pic.twitter.com/ru8Ptmk72w
— ABC News (@ABC) August 15, 2025
ABC News has more:
FluMist is a live attenuated vaccine that comes in the form of a nasal spray as a needle-free option for
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!